Brimonidine protects against loss of Thy-1 promoter activation following optic nerve crush

por Dai, Yi, Lindsey, James D, Duong-Polk, Karen X, Chindasub, Panida, Leung, Christopher Kai-Shun, Weinreb, Robert N
Publicado 2013

Protection by an Oral Disubstituted Hydroxylamine Derivative against Loss of Retinal Ganglion Cell Differentiation following Optic Nerve Crush

por Lindsey, James D., Duong-Polk, Karen X., Dai, Yi, Nguyen, Duy H., Leung, Christopher K., Weinreb, Robert N.
Publicado 2013

Increased optic atrophy type 1 expression protects retinal ganglion cells in a mouse model of glaucoma

por Ju, Won-Kyu, Kim, Keun-Young, Duong-Polk, Karen X., Lindsey, James D., Ellisman, Mark H., Weinreb, Robert N.
Publicado 2010

Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson’s Disease/Dementia with Lewy Bodies

por Price, Diana L., Rockenstein, Edward, Mante, Michael, Adame, Anthony, Overk, Cassia, Spencer, Brian, Duong-Polk, Karen X., Bonhaus, Douglas, Lindsey, James, Masliah, Eliezer
Publicado 2016

Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

por Melchior, Benoît, Mittapalli, Gopi Kumar, Lai, Carolyn, Duong‐Polk, Karen, Stewart, Joshua, Güner, Bora, Hofilena, Brian, Tjitro, Amanda, Anderson, Scott D., Herman, David S., Dellamary, Luis, Swearingen, Christopher J., Sunil, K.C., Yazici, Yusuf
Publicado 2019